Rimonabant: A cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factors
- 20 January 2006
- journal article
- review article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 16 (2) , 156-162
- https://doi.org/10.1016/j.numecd.2005.10.011
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The endocannabinoid system and its therapeutic exploitationNature Reviews Drug Discovery, 2004
- The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesisJournal of Clinical Investigation, 2003
- The endogenous cannabinoid system controls extinction of aversive memoriesNature, 2002
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Comparative biology of the endocannabinoid systemEuropean Journal of Biochemistry, 2000
- Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory actionTrends in Neurosciences, 1998
- Pharmacology of cannabinoid CB1 and CB2 receptorsPharmacology & Therapeutics, 1997
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- Cannabinoid receptor localization in brain.Proceedings of the National Academy of Sciences, 1990